Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Drug Safety|June 20, 2003
Benefit-risk assessment of treatments for heparin-induced thrombocytopeniaHarry Messmore, Walter Jeske, William Wehrmacher, et al.Comprehensive Therapy|March 29, 2005
A woman's body and her vascular system are unique. How should we care for them?William H Wehrmacher, Harry Messmore, Randall T BellowsComprehensive Therapy|November 21, 2007
Pulmonary arterial hypertensionJosé Luis Puglisi, William H Wehrmacher, Harry Messmore, et al.Comprehensive Therapy|August 20, 2005
Sudden unexpected deathW H Wehrmacher, José Luis Puglisi, Donald M Bers, et al.Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Antithrombotic Agents in the Management of SepsisOmer Iqbal, Mahmut Tobu, Debra Hoppenstead, et al.Current Pharmaceutical Design|April 14, 2004
Biochemical and pharmacologic heterogeneity in low molecular weight heparins. Impact on the therapeutic profileJawed Fareed, Debra Hoppensteadt, Christopher Schultz, et al.Expert Opinion on Emerging Drugs|July 2, 2005
Antithrombotic agents in the treatment of severe sepsisOmer Iqbal, Harry Messmore, Jawed Fareed, et al.Pageof 1